Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma

David B Zhen1, Andrew Coveler1, Silvia Zanon2

  • 1Division of Medical Oncology, Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Seminars in Oncology
|November 5, 2018
PubMed

Insights

Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer. Advances in understanding molecular changes offer new biomarker-driven therapies, including immune checkpoint inhibitors and PARP inhibitors, improving treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) presents a significant challenge due to limited effective treatments.
  • Recent advancements have elucidated key molecular alterations driving PDAC.
  • Identifying these alterations is crucial for developing targeted therapies.

Purpose of the Study:

  • To review the major biological mechanisms underlying PDAC.
  • To discuss current and future directions for molecularly targeted therapies in PDAC.
  • To highlight the impact of biomarker-driven therapeutic strategies.

Main Methods:

  • Literature review of molecular mechanisms in PDAC.
  • Analysis of current and emerging targeted therapies.
  • Evaluation of biomarker-driven treatment successes.

Main Results:

  • Significant progress has been made in understanding PDAC molecular landscape.
  • Biomarker-driven therapies, such as immune checkpoint inhibitors and PARP inhibitors, show promise.
  • Targeting hyaluronan with PEGPH20 is effective in specific patient populations.

Conclusions:

  • Molecular insights are paving the way for more effective PDAC treatments.
  • Biomarker-guided therapies represent a critical advancement in managing PDAC.
  • Future research should focus on further refining molecularly targeted approaches for PDAC.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Molecular Models02:00

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.7K
Molecular Orbital Theory II03:51

Molecular Orbital Theory II

Molecular Orbital Energy Diagrams
27.3K
Molecular Orbital Theory I02:35

Molecular Orbital Theory I

Overview of Molecular Orbital Theory
47.5K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
45.8K